Norgine SA
23.6 FTEThe score of Norgine shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Revenue +11 % Equity +24 % Total assets +99 % Headcount (avg FTE) -26 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Norgine's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | €19.1m | ||||
| Net result | 776,540 € | ||||
| Equity | €6.96m | ||||
| Cash | 208,627 € | ||||
| EBITDA | €1.08m | ||||
| Total assets | €14.1m |
Filed annual accounts
- Year ended 31 Dec 2024filed on 06 Oct 2025
- Year ended 31 Dec 2023filed on 29 Jul 2025
- Year ended 31 Dec 2022filed on 29 Apr 2024
- Year ended 31 Dec 2021filed on 31 Aug 2022
- Year ended 31 Dec 2020filed on 21 May 2021
Norgine's financial analysis
- Solvency49.5%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Norgine
Norgine's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.077.461
- VAT number
- BE0403077461
- Peppol
- Registered · 0208:0403077461 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jan 1930
- Registered office
- 3001 Leuven
- Size
- Small · 23.6 FTE
- Latest accounts
- 2024 · filed on 06 Oct 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Norgine (SA) has been based in Leuven since 1930, active in: wholesale of pharmaceutical and medical goods. For 2024, it reports revenue of €19.1m, a net profit of 776,540 € and equity of €6.96m. With 23.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 49.5%, above the median of its sector (46.0%).
Companies similar to Norgine
Companies in the same business, of comparable size and area, outside its group.
- Exphar Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €14.1m
- Melisana Wholesale of pharmaceutical and medical goods Evere · balance sheet €15.4m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- DE Ceunynck Medical Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet €16.9m
- Zambon Wholesale of pharmaceutical and medical goods Jette · balance sheet €7.67m
- P&G Health Belgium Wholesale of pharmaceutical and medical goods Grimbergen · balance sheet €20.8m
- Organon Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €25.2m
- Vantive Belgium Wholesale of pharmaceutical and medical goods Braine-l'Alleud · balance sheet €23.3m
Frequently asked questions about Norgine
What is the revenue of Norgine?
According to the 2024 annual accounts filed with the NBB, the revenue of Norgine amounts to 19,148,743 €.
What is the VAT number of Norgine?
In Belgium, the VAT number is the company number prefixed with BE: BE0403077461 for Norgine, if the company is VAT-registered. Its company number (CBE) is 0403.077.461.
Where is the registered office of Norgine?
According to the CBE register, the registered office of Norgine is in 3001 Leuven.
What is the equity of Norgine?
At the close of the 2024 financial year, the equity of Norgine amounts to 6,956,923 €, a solvency of 49.5% of total assets.
How many people work at Norgine?
23.6 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Norgine?
The register lists 4 active mandates at Norgine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Norgine
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →